T

The Profit Prescription

$PROSPERXGGary T.

About The Profit Prescription

At its core, the portfolio leverages agile, algorithm-driven trades alongside carefully researched, undervalued positions. Rigorous risk management strategies, including precise stop-loss measures and tactical hedging, ensure that while the portfolio aggressively pursues gains, it also minimizes potential downside. This portfolio stands as a testament to the power of disciplined, innovative investing. Whether navigating volatile markets or capitalizing on emerging trends, this portfolio not only delivers exceptional returns but also sets a new standard for excellence in investment management.

About the Creator

Gary Touchette is a seasoned healthcare executive and project manager with 30 years of investing expertise. His deep roots in the healthcare industry and years at the helm of complex projects have uniquely positioned him to navigate market intricacies with precision. Gary’s investment approach combines traditional market wisdom with modern, agile trading strategies designed to consistently deliver gains and maximize returns.

Leveraging a blend of AI, fundamental and technical analysis, Gary meticulously researches and identifies undervalued opportunities—particularly in sectors he knows best—while also capitalizing on short-term market trends. His strategy employs a diversified mix of long-term positions and nimble, algorithm-driven trades that adapt to evolving market conditions. By utilizing robust risk management techniques, including strategic stop-losses and portfolio hedging, he minimizes downside risk while unlocking significant growth potential.

Activity

Total Rebalances14
Last RebalanceMay 29, 2026

Posts by Creator

See all
Changes:DDOG +10.0%MU +2.4%SNDK +1.6%SOXL +1.6%LITE -12.5%

$PROSPERX I am closing our position in Lumentum Holdings to reallocate capital into Datadog based on a shift toward stronger long-term growth, recurring revenue visibility, and expanding enterprise software demand. While Lumentum remains a quality company with exposure to optical networking and telecom infrastructure, its growth outlook is currently more cyclical and tied to hardware spending trends.

Changes:SOXL +3.9%TQQQ +3.9%SPXL +3.9%COHR +0.6%SNDK -5.5%

I am rebalancing the Profit Prescription portfolio to lock in gains from the recent run in semiconductors and memory. While these sectors remain core to the AI stack, current consolidation signals a shift toward capital preservation. I am rotating profits into broader S&P 500 exposure to reduce volatility, while maintaining a tactical watch on moving averages and momentum indicators to re-enter the memory / semiconductor space stronger when the trend stabilizes.

Changes:SOXL +2.6%TQQQ +2.6%SPXL +2.6%WDC +1.2%SNDK +1.0%

Removing SMH and spreading its allocation across fast moving leveraged funds.